ADGM Quote, Financials, Valuation and Earnings

Henry Schein has a net margin of -- compared to Adagio Medical Holdings's net margin of 2.95%. Adagio Medical Holdings's return on equity of -- beat Henry Schein's return on equity of 7.8%.

Adagio Medical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Henry Schein has an analysts' consensus of $77.96 which suggests that it could grow by 23.18%. Given that Henry Schein has higher upside potential than Adagio Medical Holdings, analysts believe Henry Schein is more attractive than Adagio Medical Holdings.

Adagio Medical Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Henry Schein has a beta of 0.844, suggesting its less volatile than the S&P 500 by 15.587%.

Adagio Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Henry Schein offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings pays -- of its earnings as a dividend. Henry Schein pays out -- of its earnings as a dividend.

Adagio Medical Holdings quarterly revenues are --, which are smaller than Henry Schein quarterly revenues of $3.2B. Adagio Medical Holdings's net income of -$245.9K is lower than Henry Schein's net income of $94M. Notably, Adagio Medical Holdings's price-to-earnings ratio is 218.00x while Henry Schein's PE ratio is 20.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings is 61.58x versus 0.64x for Henry Schein. Usually stocks with elevated PS ratios are considered overvalued.

Standard BioTools has a net margin of -- compared to Adagio Medical Holdings's net margin of -72.93%. Adagio Medical Holdings's return on equity of -- beat Standard BioTools's return on equity of -36.54%.

Adagio Medical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Standard BioTools has an analysts' consensus of $2.38 which suggests that it could grow by 110.18%. Given that Standard BioTools has higher upside potential than Adagio Medical Holdings, analysts believe Standard BioTools is more attractive than Adagio Medical Holdings.

Adagio Medical Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Standard BioTools has a beta of 1.541, suggesting its more volatile than the S&P 500 by 54.101%.

Adagio Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings pays -- of its earnings as a dividend. Standard BioTools pays out -- of its earnings as a dividend.

Adagio Medical Holdings quarterly revenues are --, which are smaller than Standard BioTools quarterly revenues of $46.7M. Adagio Medical Holdings's net income of -$245.9K is higher than Standard BioTools's net income of -$34.1M. Notably, Adagio Medical Holdings's price-to-earnings ratio is 218.00x while Standard BioTools's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings is 61.58x versus 2.29x for Standard BioTools. Usually stocks with elevated PS ratios are considered overvalued.

LENSAR has a net margin of -- compared to Adagio Medical Holdings's net margin of -111.78%. Adagio Medical Holdings's return on equity of -- beat LENSAR's return on equity of -134.77%.

Adagio Medical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand LENSAR has an analysts' consensus of $15.00 which suggests that it could grow by 9.09%. Given that LENSAR has higher upside potential than Adagio Medical Holdings, analysts believe LENSAR is more attractive than Adagio Medical Holdings.

Adagio Medical Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison LENSAR has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Adagio Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings pays -- of its earnings as a dividend. LENSAR pays out -- of its earnings as a dividend.

Adagio Medical Holdings quarterly revenues are --, which are smaller than LENSAR quarterly revenues of $16.7M. Adagio Medical Holdings's net income of -$245.9K is higher than LENSAR's net income of -$18.7M. Notably, Adagio Medical Holdings's price-to-earnings ratio is 218.00x while LENSAR's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings is 61.58x versus 2.96x for LENSAR. Usually stocks with elevated PS ratios are considered overvalued.

Patterson Companies has a net margin of -- compared to Adagio Medical Holdings's net margin of 1.99%. Adagio Medical Holdings's return on equity of -- beat Patterson Companies's return on equity of 14.22%.

Adagio Medical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Patterson Companies has an analysts' consensus of $30.42 which suggests that it could fall by -2.92%. Given that Patterson Companies has higher upside potential than Adagio Medical Holdings, analysts believe Patterson Companies is more attractive than Adagio Medical Holdings.

Adagio Medical Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Patterson Companies has a beta of 0.731, suggesting its less volatile than the S&P 500 by 26.948%.

Adagio Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Patterson Companies offers a yield of 3.32% to investors and pays a quarterly dividend of $0.26 per share. Adagio Medical Holdings pays -- of its earnings as a dividend. Patterson Companies pays out 52.89% of its earnings as a dividend. Patterson Companies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Adagio Medical Holdings quarterly revenues are --, which are smaller than Patterson Companies quarterly revenues of $1.6B. Adagio Medical Holdings's net income of -$245.9K is lower than Patterson Companies's net income of $31.3M. Notably, Adagio Medical Holdings's price-to-earnings ratio is 218.00x while Patterson Companies's PE ratio is 20.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings is 61.58x versus 0.43x for Patterson Companies. Usually stocks with elevated PS ratios are considered overvalued.